EGFR (IHC)Print this page
Updated Test Information:
Epidermal Growth Factor Receptor
Epidermal Growth Factor Receptor (EGFR) overexpression can occur in a variety of tumor types, including breast, prostate, ovarian, brain, lung and predominantly squamous cell carcinomas. Tumors that express EGFR are associated with a poor prognosis and a shorter disease-free survival. Most colon carcinomas will show expression of EGFR in more than 1% of the invasive tumor cells. Patients whose tumor expresses EGFR are eligible for cetuximab therapy although the response to therapy is independent of the intensity or percentage of cells staining.
Complete the Incyte Diagnostics requisition with the patient's demographics and relevant clinical history.
Use cold pack for transport. Make sure cold pack is not in direct contact with specimen.